EUVIMEDEUVIMED entdecken
Crossref

Obesity, Sarcopenia, Sarcopenic Obesity, and Hypertension: Mediating Role of Inflammation and Insulin Resistance

Yuanlin Zou, Hua Ye, Ziqing Xu, Qian Yang, Jicun Zhu, Tiandong Li, Yifan Cheng, Yongjian Zhu, Junxi Zhang, Yacong Bo, Peng Wang iD

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 10.02.2025 · 80 (3)

DOI: 10.1093/gerona/glae284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 07.02.2025. Verfasst von Yuanlin Zou und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Public Health, Zhengzhou University, Zhengzhou 450001, Henan Province, China. Hauptthemen laut MEDLINE: Sarcopenia, Obesity, Insulin Resistance, Inflammation. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Henan Key Research and Development Project, Tackling Key Problems in Science and Technology of Henan Province, Open Research Fund of the National Health Commission Key Laboratory of Birth Defects Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to assess the association between obesity, sarcopenia, and sarcopenic obesity with hypertension and to explore the potential mediation of inflammation indicators and insulin resistance.

Methods

Data from the UK Biobank, a large-scale prospective cohort, were utilized. Obesity was defined using percentage of fat mass, whereas sarcopenia was defined as low muscle mass and low muscle strength. The primary outcome assessed was new-onset hypertension within a 5-year follow-up period. The association analysis was examined using a Cox regression model.

Results

A total of 183 091 participants were enrolled in this study. During 5 years of follow-up, 3 812 (2.08%) developed hypertension. In the fully adjusted model, compared to men without these conditions, those with obesity, sarcopenia, and sarcopenic obesity had 2.32 times (95% confidence interval [95% CI], 2.12–2.55), 3.10 times (95% CI, 2.35–4.08), and 3.66 times (95% CI, 2.98–4.50) higher risks of developing hypertension, respectively. Women with obesity, sarcopenia, and sarcopenic obesity had 2.27 times (95% CI, 2.03–2.54), 2.93 times (95% CI, 1.95–4.39), and 4.04 times (95% CI, 3.32–4.91) higher risks of hypertension, respectively. Significant mediating effects of C-reactive protein, neutrophils, white blood cells, triglyceride-glucose index, and triglyceride-to-high-density lipoprotein cholesterol ratio were found, with mediations ranging from 6% to 13% for men and 2% to 21% for women in the association between sarcopenic obesity and hypertension.

Conclusions

Obesity, sarcopenia, and sarcopenic obesity significantly increased the risk of hypertension. Inflammation and insulin resistance appeared to mediate the association between sarcopenic obesity and hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaObesityInsulin ResistanceInflammationHypertensionHumansMaleFemaleMiddle AgedAgedProspective StudiesRisk FactorsUnited Kingdom

Stichwörter der Autor:innen

HypertensionObesitySarcopeniaSarcopenic obesity

Autor:innen und Institutionen

  • College of Public Health, Zhengzhou University, Zhengzhou 450001, Henan Province, China.
  • Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou 450052, Henan Province, China.
  • Prenatal Diagnosis Center, The Third Affiliated Hospital of Zhengzhou University/Maternal and Child Health Hospital of Henan Province, Zhengzhou 450052, Henan Province, China.
  • Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China.
  • Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China.
  • NHC Key Laboratory of Birth Defects Prevention and Henan Key Laboratory of Population Defects Prevention, Zhengzhou 450002, Henan Province, China.

ORCID-Profile: Peng Wang

Förderung

  • Henan Key Research and Development Project
  • Tackling Key Problems in Science and Technology of Henan Province
  • Open Research Fund of the National Health Commission Key Laboratory of Birth Defects Prevention
  • Henan Key Laboratory of Population Defects Prevention

Zitieren

APA

Zou, Y., Ye, H., Xu, Z., Yang, Q., Zhu, J., Li, T., Cheng, Y., Zhu, Y., Zhang, J., Bo, Y., & Wang, P. (2025). Obesity, Sarcopenia, Sarcopenic Obesity, and Hypertension: Mediating Role of Inflammation and Insulin Resistance. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 80(3). https://doi.org/10.1093/gerona/glae284

Vancouver

Zou Y, Ye H, Xu Z, Yang Q, Zhu J, Li T, et al. Obesity, Sarcopenia, Sarcopenic Obesity, and Hypertension: Mediating Role of Inflammation and Insulin Resistance. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025;80(3). doi:10.1093/gerona/glae284

BibTeX
@article{Zou2025,
  author = {Zou, Yuanlin and Ye, Hua and Xu, Ziqing and Yang, Qian and Zhu, Jicun and Li, Tiandong and Cheng, Yifan and Zhu, Yongjian and Zhang, Junxi and Bo, Yacong and Wang, Peng},
  title = {Obesity, Sarcopenia, Sarcopenic Obesity, and Hypertension: Mediating Role of Inflammation and Insulin Resistance},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2025},
  volume = {80},
  number = {3},
  doi = {10.1093/gerona/glae284}
}
Kostenlos starten →